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INTRODUCTION
Ginseng has been used as a medicinal plant for more than
2000 yr in Asian countries. In fact, various pharmacological
activities have been found in ginseng extract or its consti-
tuents. Among them, anti-carcinogenic effect seems to be
especially important, since development of effective method
for cancer prevention is urgent problem not only in Asian
countries but also in all over the world. Inhibitory effect of
red ginseng extracts on pulmonary carcinogenesis has already
been well documented (1). And tendency of suppression on
liver carcinogensis has also reported (1). Thus, at first, we
have extended the study on inhibitory effect of red ginseng
extracts in liver carcinogensis using other experimental mod-
els. Furthermore, anti-carcinogenic activity of white gin-
seng extracts, besides red ginseng extracts, was also investi-
gated.
MATERIALS AND METHODS
Materials
Extracts of ginseng (Panax ginseng C.A. Meyer) were pre-
pared as dried powder from the dilute ethanol extracts, and
provided by Wakunaga Pharmaceutical Co., Ltd. (Hiroshi-
ma, Japan). In some cases, dried sample prepared from hot
water extract of ginseng was used. Dried preparation of Ren-
Shen-Yang-Rong-Tang extract was also prepared from its
hot water extract. Ren-Shen-Yang-Rong-Tang, a Chinese
medicinal prescription, is consisted of ginseng (Renshen)
and other 11 Chinese drugs (Baizhu, Ganjiang, Guizhi,
Huangqi, Danggui, Chenpi, Fuling, Shudihuang, Shaoyao,
Wuweizi and Yuanzhi).
7,12-Dimethylbenz[a]anthracene (DMBA) was purchased
from Wako Pure Chemical Industries (Osaka, Japan). 12-o-
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Cancer Chemoprevention by Ginseng in Mouse Liver and Other
Organs
Oral administration of red ginseng extracts (1% in diet for 40 weeks) resulted in
the significant suppression of spontaneous liver tumor formation in C3H/He
male mice. Average number of tumors per mouse in control group was 1.06,
while that in red ginseng extracts-treated group was 0.33 (p<0.05). Incidence of
liver tumor development was also lower in red ginseng extracts-treated group,
although the difference from control group was not statistically significant. Anti-
carcinogenic activity of white ginseng extracts, besides red ginseng extracts,
was also investigated. In the present study, the administration of white ginseng
extracts was proven to suppress tumor promoter-induced phenomena in vitro
and in vivo. It is of interest that oral administration of the extracts of Ren-Shen-
Yang-Rong-Tang, a white ginseng-containing Chinese medicinal prescription,
resulted in the suppression of skin tumor promotion by 12-o-tetradecanoylphor-
bol-13-acetate in 7,12-dimethylbenz[a]anthracene-initiated CD-1 mice. These
results suggest the usefulness of ginseng in the field of cancer prevention.
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Skin Neoplasmstetradecanoylphorbol-13-acetate (TPA) was obtained from
Sigma-Aldrich Corporation (St. Louis, MO, U.S.A.).
In vivo mouse spontaneous liver carcinogenesis experi-
ment
C3H/He male mice, which have a high incidence of spon-
taneous liver tumor development, were used. Mice were pur-
chased from Charles River Japan (Tokyo, Japan). Red gin-
seng extracts were administrated orally. Mice were killed at
experimental week 40 by cervical dislocation, and the num-
ber of liver tumor nodules was counted.
In vivo two-stage mouse skin carcinogenesis experi-
ment
CD-1 female mice (purchased from Charles River Japan,
Tokyo, Japan) had their backs shaved with an electric mouse
hair clipper. Initiation was accomplished by a single appli-
cation of DMBA (585 nmol) on the shaved area. TPA, at
the dose of 3.24 nmol, was applied twice a week starting 1
week after initiation. The experiment was continued for 18
weeks.
Effect on TPA-induced Epstein-Barr virus activation
in Raji cells
Effect on Epstein-Barr virus (EBV)-early antigen (EA)
induction by TPA was examined using Raji cells, which is
EBV genome-carrying human lymphoblastoid cell line.
Cells were incubated for 48 hr in 1 mL of culture medium
containing n-butyric acid (4 mM), TPA (32 nM), and test
compound or its vehicle. Smears were made from cell sus-
pension. The cells were stained with EBV-EA positive sera
obtained from nasopharyngeal carcinoma patients, and detect-
ed by a conventional indirect immunofluorescence technique.
In each assay, at least 500 cells were counted and the experi-
ments were repeated twice. The average EA induction was
compared with that of the positive control experiment with
n-butyric acid (4 mM) plus TPA (32 nM).
RESULTS
Inhibitory effect of red ginseng extracts on liver carcino-
genesis
Effect of oral administration of red ginseng extracts on
liver carcinogensis was studied using the experimental model
of spontaneous liver carcinogenesis in C3H/He male mice.
Dried powder of red ginseng extracts prepared from dilute
ethanol extract was mixed into diet at the final concentra-
tion of 1%.
Consumption of diet in each group was almost the same,
and no significant difference in final body weight was observed
(33.6±0.5 g in control group, and 34.4±0.6 g in red gin-
seng extracts administered group, respectively).
As shown in Table 1, the mean number of liver tumors
was significantly decreased by administration of red ginseng
extracts as compared with that in the control group; the
control group developed 1.06 tumors/mouse, whereas the 1%
red ginseng extracts treated group had 0.33 tumors/mouse
(p<0.05, Student’ s t-test). The incidence of tumor develop-
ment was also lower in red ginseng extracts treated group
than in control group, although the difference from control
was not statistically significant. There were no differences in
histological findings of tumors among the groups. The tumor
cells were arranged in thin trabecular structures surrounded
by sinusoidal structures. The nuclei of the tumor cells were
slightly enlarged, and mitoses were seen sporadically, but
pleomorphism was not so profound and the tumor was iden-
tified as well-differentiated hepatocellular carcinoma.
Anti-tumor promoting effect of white ginseng extracts
In order to evaluate the anti-carcinogenic activity of white
ginseng, besides red ginseng, we have examined the poten-
cy of white ginseng extracts to suppress tumor promoter-
induced phenomena in vitro and in vivo.
As shown in Table 2, white ginseng extracts suppressed
EBV-EA expression in Raji cells induced by TPA, a typical
tumor promoter. Inhibitory effect of white ginseng extracts
was observed in a dose-dependent manner, and complete
suppression was achieved at the concentration of 100  g/mL.
These results of in vitro study prompted us to examine in
vivo anti-tumor promoting activity of white ginseng extracts.
As shown in Table 3, skin tumor promotion by TPA was
suppressed by oral administration of white ginseng extracts
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*p<0.05 (Student’ s t-test).
Group (n)
Tumor-bearing
mice (%)
Number of tumors per
mouse (mean±SE)
Control (16) 43.8 1.06±0.37*
+Red ginseng  (12) 33.3 0.33±0.14*
extracts
Table 1. Effect of red ginseng extracts on spontaneous liver
carcinogensis in C3H/He male mice
Concentration of
white ginseng extracts (mg/mL)
Inhibition %
0 (Control) 0
10
10 31.7
50 65.1
100 100
Table 2. Effect of white ginseng extracts on TPA-induced
expression of Epstein-Barr virus early antigen in Raji cells(in this case, dried sample prepared from hot water extracts
was used), although the effect was not statistically signifi-
cant. It is of interest that the administration of the extracts
of Ren-Shen-Yang-Rong-Tang, one of the white ginseng-
containing Chinese medicinal prescriptions, resulted in sig-
nificant suppression of skin tumor promotion.
DISCUSSIONS
Oral administration of red ginseng extracts (1% in diet)
was proven to suppress mouse liver carcinogenesis. As men-
tioned above, tendency of anti-liver carcinogenic activity of
red ginseng extracts has already been reported (1). Thus,
usefulness of red ginseng in liver cancer prevention is well
confirmed.
Since white ginseng, besides red ginseng, is also widely
used, we have examined the anti-carcinogenic activity of
white ginseng extracts. In the present study, anti-tumor pro-
moting activity was investigated. As the results, the admin-
istration of white ginseng extracts was proven to suppress
TPA-induced phenomena in vitro and in vivo.
Anti-tumor promoting activity of white ginseng extracts
is now evaluating using experimental model of two-stage
carcinogenesis in lung, besides skin. In a preliminary exper-
iment, white ginseng extracts showed inhibitory effect on
lung tumor promotion in a dose-dependent manner. In 4-
nitroquinoline 1-oxide-initiated and glycerol-promoted lung
carcinogenesis experiment, the effect of white ginseng extracts
(oral administration during tumor promoting stage, added
into drinking water), was apparent at the dose of 0.04%.
And statistically significant suppression was observed at the
dose of 0.1%.
Administration of red ginseng extracts at the dose of 0.1%
in drinking water was also effective to suppress lung tumor
promotion. As mentioned above, significant anti-lung car-
cinogenic activity of red ginseng extracts has already been
reported (1). Thus, usefulness of red ginseng in lung cancer
prevention is well confirmed.
From these results, both of red and white ginseng seem to
be valuable in cancer control.
Since various species of ginseng, such as Panax japonicus
C.A. Meyer (Japanese ginseng, Bamboo ginseng), Panax
notoginseng (Burk) F. H. Chen (Sanchi-ginseng), Panax viet-
namensis Ha et Grusho (Vietnamese ginseng), besides Panax
ginseng C.A. Meyer, are used as medicinal plant in the world,
it is of interest to evaluate these ginseng products.
Identification of active principles in red and white ginseng
is also important. Various kinds of ginsenosides were already
isolated, and some of them have been evaluated. For exam-
ple, ginsenosides Rb1 and Rb2 were proven to have anti-
tumor promoter activity in vitro. Furthermore, oral admin-
istration of ginsenoside Rb1-rich fraction resulted in strong
suppression of mouse skin tumor promotion (unpublished
data).
Recently, we have also identified majonoside-R2 as an
anti-tumor promoting principle in Vietnamese ginseng (2).
Among seven saponins isolated from this plant, majono-
side-R2 showed the strongest inhibitory effect on EBV-EA
expression induced by TPA in Raji cells. And majonoside-
R2 was further proven to show potent anti-tumor promot-
ing activity in two-stage skin carcinogensis.
Ginseng-containing Chinese medicinal prescriptions are
also worthy to investigate their anti-carcinogenic potency
more intensively. In this paper, anti-tumor promoting activi-
ty of Ren-Shen-Yang-Rong-Tang is demonstrated in two-
stage carcinogensis of mouse skin. Combination of active
principles in ginseng and other drugs in this prescription
may synergistically strengthen the anti-carcinogenic activi-
ty. In fact, gomisin A isolated from Wuweizi, a component
of this prescription, has already found to suppress two-stage
mouse skin carcinogensis (3).
In conclusion, usefulness of ginseng in the field of cancer
prevention has been suggested experimentally, and further
investigation including clinical trials should be continued.
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*p<0.01 (Student’ s t-test).
Group (n)
Tumor-bearing
mice (%)
Number of tumorsper
mouse (mean±SE)
Control (15) 100 15.00±2.38*
+White ginseng extracts (15) 86.6 10.53±2.34
(0.04% in drinking water)
+Ren-Shen-Yang-Rong- (14) 64.3 3.00±0.93*
Tang extracts
(0.1% in drinking water)
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